KW
Insider
Kory James Wentworth
Chief Financial OfficerKory James Wentworth (Chief Financial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Entrada Therapeutics, Inc. (TRDA). The largest single filing was $148K of TRDA (11,388 sh × $13.02, as filed), executed Mar 10.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$148K
shares × price, as filed
Last traded
Mar 10
Filed Mar 11
Median ADV $2.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $421K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
TRDARecent filings
TRDASALE
Entrada Therapeutics, Inc.
View filing →
$148K11,388 sh × $13.02
Exec Mar 10
Filed Mar 11 · 5:30 PM ET TRDASALE Entrada Therapeutics, Inc. View filing → $100K
5,000 sh × $20.00
Exec Dec 2 2024
Filed Dec 3 2024 · 5:30 PM ET TRDASALE Entrada Therapeutics, Inc. View filing → $173K
8,637 sh × $19.98
Exec Nov 11 2024
Filed Nov 13 2024 · 5:30 PM ET